SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer's Disease Patients.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) triggered the pandemic Coronavirus Disease 19 (COVID-19), causing millions of deaths. The elderly and those already living with comorbidity are likely to die after SARS-CoV-2 infection. People suffering from Alzheimer's disease (AD) have a higher risk of becoming infected, because they cannot easily follow health roles. Additionally, those suffering from dementia have a 40% higher risk of dying from COVID-19. Herein, we collected from Gene Expression Omnibus repository the brain samples of AD patients who died of COVID-19 (AD+COVID-19), AD without COVID-19 (AD), COVID-19 without AD (COVID-19) and control individuals. We inspected the transcriptomic and interactomic profiles by comparing the COVID-19 cohort against the control cohort and the AD cohort against the AD+COVID-19 cohort. SARS-CoV-2 in patients without AD mainly activated processes related to immune response and cell cycle. Conversely, 21 key nodes in the interactome are deregulated in AD. Interestingly, some of them are linked to beta-amyloid production and clearance. Thus, we inspected their role, along with their interactors, using the gene ontologies of the biological process that reveals their contribution in brain organization, immune response, oxidative stress and viral replication. We conclude that SARS-CoV-2 worsens the AD condition by increasing neurotoxicity, due to higher levels of beta-amyloid, inflammation and oxidative stress.

• Authors: Luigi Chiricosta, Agnese Gugliandolo, Emanuela Mazzon
• Journal: International journal of molecular sciences (Int J Mol Sci) Vol. 22 Issue 24 (Dec 19 2021) ISSN: 1422-0067 [Electronic] Switzerland
• PMID: 34948400 (Publication Type: Journal Article)

Chemical References

• Amyloid beta-Peptides

Topics

• Alzheimer Disease (complications, genetics, virology)
• Amyloid beta-Peptides (metabolism)
• Brain (virology)
• COVID-19 (complications, genetics, physiopathology)
• Comorbidity (trends)
• Databases, Factual
• Gene Expression (genetics)
• Gene Expression Profiling (methods)
• Humans
• Inflammation (metabolism)
• Neurotoxicity Syndromes (metabolism)
• Oxidative Stress (physiology)
• Pandemics
• SARS-CoV-2 (metabolism, pathogenicity)
• Transcriptome (genetics)